Position in LLY
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$39,686,743
+$7,480,997 QoQ
Shares Held
33,088
-5.5% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.45%
of 13F equity value
Holder Rank
#610
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 65%
Shared 0%
None 35%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Derivatives in LLY
reported options exposure · as of Sep 30, 2025CallValue
$0
CallShares
0
PutValue
$1,144,500
PutShares
1,500
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026JOHNSON INVESTMENT COUNSEL INC holds $156,508,696 across 14 Drug Manufacturers - General names. LLY ranks #2 (25.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
170,334 | $43,259,725 | |
| 2 | LLY |
ELI LILLY & Co
This page
|
33,088 | $39,686,743 | |
| 3 | ABBV |
AbbVie Inc.
|
155,264 | $39,070,632 | |
| 4 | MRK |
Merck & Co., Inc.
|
96,505 | $12,400,892 | |
| 5 | AMGN |
Amgen Inc
|
23,570 | $8,535,168 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
93,509 | $5,387,988 | |
| 7 | PFE |
Pfizer Inc
|
100,100 | $2,410,408 | |
| 8 | NVS |
Novartis AG
|
12,976 | $2,033,598 |
All Filings in LLY
Export CSV
29 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $39,686,743 | 33,088 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $32,205,746 | 35,015 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $38,139,322 | 35,489 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $27,110,153 | 35,531 | Shares | Sole | 2025-11-06 | |
| 2025-09-30 | $1,144,500 | 1,500 | Put | Sole | 2025-11-06 | |
| 2025-06-30 | $1,169,295 | 1,500 | Put | Sole | 2025-07-25 | |
| 2025-06-30 | $27,110,494 | 34,778 | Shares | Sole | 2025-07-25 | |
| 2025-03-31 | $2,477,730 | 3,000 | Put | Sole | 2025-04-21 | |
| 2025-03-31 | $28,326,235 | 34,297 | Shares | Sole | 2025-04-21 | |
| 2024-12-31 | $26,708,884 | 34,597 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $30,094,495 | 33,969 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $30,644,396 | 33,847 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $27,032,554 | 34,748 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $14,666,267 | 25,160 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $13,361,645 | 24,876 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $11,805,633 | 25,173 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $8,788,461 | 25,591 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $9,503,059 | 25,976 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $7,978,984 | 24,676 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $7,968,600 | 24,577 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $6,811,596 | 23,786 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $6,727,614 | 24,356 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $5,609,894 | 24,280 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $5,645,962 | 24,599 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $4,709,358 | 25,208 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $4,320,784 | 25,591 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $3,967,084 | 26,801 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $4,364,068 | 26,581 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $4,092,933 | 29,505 | Shares | Sole | 2020-05-20 | |
| No filing history on record for this holder in this stock. | ||||||